Contemporary management of stent thrombosis: Predictors of mortality and the role of new‐generation drug‐eluting stents
- 9 September 2019
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (1) , E8-E16
Abstract
Objectives: We sought to evaluate mortality predictors and the role of new‐generation drug‐eluting stents (NG‐DES) in stent thrombosis (ST) management.Background: No data are available regarding the outcome of patients with ST after interventional management that includes exclusively NG‐DES.Methods: Patients with definite ST of DES or BMS who underwent urgent/emergent angiography between 2015 and 2018 at our institution were considered for the study. After excluding patients who achieved TIMI‐flowp = .01), TIMI‐2 flow (HR 7.4, p = .002) and GFR < 60 mL/min (HR 3.8, p = .01) were independent predictors of ACD. The stent‐treatment group had significantly better ACD‐free survival after discharge, both unadjusted (p = .022) and adjusted (p = .018).Conclusions: After ST management, different predictors were observed for in‐hospital mortality and mortality in patients discharged alive. The better outcome with NG‐DES treatment is a novel observation, warranting further studies to elucidate if it is associated with stent‐related or patient‐related factors.Keywords
This publication has 20 references indexed in Scilit:
- Predictors of stent thrombosis and their implications for clinical practiceNature Reviews Cardiology, 2018
- Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trialThe Lancet, 2018
- Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trialThe Lancet, 2016
- 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical TrialsJACC, 2015
- Stent ThrombosisJACC: Cardiovascular Interventions, 2014
- Long-Term Outcome After Angiographically Proven Coronary Stent ThrombosisThe American Journal of Cardiology, 2013
- Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trialThe Lancet, 2012
- Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent ThrombosisJACC: Cardiovascular Interventions, 2012
- Drug-Eluting Stent ThrombosisJACC, 2008
- Adjusted Kaplan–Meier estimator and log‐rank test with inverse probability of treatment weighting for survival dataStatistics in Medicine, 2005